Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer - PubMed (original) (raw)
. 2015 Oct;110(10):1461-71; quiz 1472.
doi: 10.1038/ajg.2015.248. Epub 2015 Sep 29.
Affiliations
- PMID: 26416190
- PMCID: PMC4697133
- DOI: 10.1038/ajg.2015.248
Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer
Chang-ho Ryan Choi et al. Am J Gastroenterol. 2015 Oct.
Abstract
Objectives: The aim of this study was to identify risk factors associated with development of high-grade dysplasia (HGD) or colorectal cancer (CRC) in ulcerative colitis (UC) patients diagnosed with low-grade dysplasia (LGD).
Methods: Patients with histologically confirmed extensive UC, who were diagnosed with LGD between 1993 and 2012 at St Mark's Hospital, were identified and followed up to 1 July 2013. Demographic, endoscopic, and histological data were collected and correlated with the development of HGD or CRC.
Results: A total of 172 patients were followed for a median of 48 months from the date of initial LGD diagnosis (interquartile range (IQR), 15-87 months). Overall, 33 patients developed HGD or CRC (19.1% of study population; 20 CRCs) during study period. Multivariate Cox proportional hazard analysis revealed that macroscopically non-polypoid (hazard ratio (HR), 8.6; 95% confidence interval (CI), 3.0-24.8; P<0.001) or invisible (HR, 4.1; 95% CI, 1.3-13.4; P=0.02) dysplasia, dysplastic lesions ≥1 cm in size (HR, 3.8; 95% CI, 1.5-13.4; P=0.01), and a previous history of "indefinite for dysplasia" (HR, 2.8; 95% CI, 1.2-6.5; P=0.01) were significant contributory factors for HGD or CRC development. Multifocal dysplasia (HR, 3.9; 95% CI, 1.9-7.8; P<0.001), metachronous dysplasia (HR, 3.5; 95% CI, 1.6-7.5; P=0.001), or a colonic stricture (HR, 7.4; 95% CI, 2.5-22.1; P<0.001) showed only univariate correlation to development of HGD or CRC.
Conclusions: Lesions that are non-polypoid or endoscopically invisible, large (≥1 cm), or preceded by indefinite dysplasia are independent risk factors for developing HGD or CRC in UC patients diagnosed with LGD.
Figures
Figure 1
Lesion shape categorization. Discrete sessile, (a) pedunculated (b), or sub-pedunculated lesions (c) that were well circumscribed from the surrounding mucosa were classifi ed as “polypoid” LGD. Superfi cially raised (d and e), visible fl at (f), irregular, or plaque-like lesions were classifi ed as “nonpolypoid” LGD.
Figure 2
Kaplan–Meier plots showing cumulative risk of developing high-grade dysplasia (HGD) or colorectal cancer (CRC). (a) Overall cumulative risk. (b) Cumulative risk by low-grade dysplasia (LGD) lesion shape. (c) Cumulative risk by LGD lesion size. (d) Cumulative risk depending on the presence or absence of preceding indefinite dysplasia.
Figure 3
Kaplan–Meier plot showing the cumulative risk of high-grade dysplasia (HGD) or colorectal cancer (CRC) development depending on total number of risk factors present (i.e., any combinations of nonpolypoid or invisible low-grade dysplasia (LGD), LGD sized ≥1 cm, and/or preceding indefinite dysplasia).
Comment in
- Clarity and caution in the natural history of low-grade dysplasia in ulcerative colitis.
Kisiel JB, Loftus EV. Kisiel JB, et al. Am J Gastroenterol. 2015 Oct;110(10):1473-4. doi: 10.1038/ajg.2015.315. Am J Gastroenterol. 2015. PMID: 26465907 Free PMC article.
Similar articles
- Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP. Navaneethan U, et al. J Crohns Colitis. 2013 Dec;7(12):e684-91. doi: 10.1016/j.crohns.2013.06.006. Epub 2013 Jul 31. J Crohns Colitis. 2013. PMID: 23916526 - Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U. Venkatesh PG, et al. J Crohns Colitis. 2013 Dec;7(12):968-73. doi: 10.1016/j.crohns.2013.02.002. Epub 2013 Feb 20. J Crohns Colitis. 2013. PMID: 23433613 - Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Goldstone R, Itzkowitz S, Harpaz N, Ullman T. Goldstone R, et al. Gastrointest Endosc. 2011 Nov;74(5):1087-93. doi: 10.1016/j.gie.2011.06.028. Epub 2011 Sep 10. Gastrointest Endosc. 2011. PMID: 21907984 - Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U. Sjöqvist U. Langenbecks Arch Surg. 2004 Oct;389(5):354-60. doi: 10.1007/s00423-003-0455-6. Epub 2004 Mar 13. Langenbecks Arch Surg. 2004. PMID: 15605166 Review. - Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
Fumery M, Dulai PS, Gupta S, Prokop LJ, Ramamoorthy S, Sandborn WJ, Singh S. Fumery M, et al. Clin Gastroenterol Hepatol. 2017 May;15(5):665-674.e5. doi: 10.1016/j.cgh.2016.11.025. Epub 2016 Dec 1. Clin Gastroenterol Hepatol. 2017. PMID: 27916678 Free PMC article. Review.
Cited by
- ATG10-dependent autophagy is required for DDX10 to regulate cell proliferation, apoptosis and stemness in colorectal cancer.
Wang K, Zhan H, Fan S, Chu S, Xu H, Jiang H. Wang K, et al. J Cancer Res Clin Oncol. 2024 Aug 7;150(8):386. doi: 10.1007/s00432-024-05910-3. J Cancer Res Clin Oncol. 2024. PMID: 39110225 Free PMC article. - Low coverage whole genome sequencing of low-grade dysplasia strongly predicts colorectal cancer risk in ulcerative colitis.
Al Bakir I, Curtius K, Cresswell GD, Grant HE, Nasreddin N, Smith K, Nowinski S, Guo Q, Belnoue-Davis HL, Fisher J, Clarke T, Kimberley C, Mossner M, Dunne PD, Loughrey MB, Speight A, East JE, Wright NA, Rodriguez-Justo M, Jansen M, Moorghen M, Baker AM, Leedham SJ, Hart AL, Graham TA. Al Bakir I, et al. medRxiv [Preprint]. 2024 Jul 8:2024.07.08.24309811. doi: 10.1101/2024.07.08.24309811. medRxiv. 2024. PMID: 39040198 Free PMC article. Preprint. - Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy.
Sakakibara R, Sugimoto S, Takabayashi K, Kiyohara H, Wakisaka Y, Kaieda Y, Kawaida M, Yoshimatsu Y, Sujino T, Hosoe N, Kato M, Shimoda M, Mikami Y, Iwao Y, Kanai T. Sakakibara R, et al. Intest Res. 2024 Oct;22(4):428-438. doi: 10.5217/ir.2024.00006. Epub 2024 May 7. Intest Res. 2024. PMID: 38712359 Free PMC article. - The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease.
Axelrad JE, Rubin DT. Axelrad JE, et al. Clin Gastroenterol Hepatol. 2024 Jun;22(6):1181-1185. doi: 10.1016/j.cgh.2024.01.030. Epub 2024 Feb 29. Clin Gastroenterol Hepatol. 2024. PMID: 38432648 Review. - Advancements in Endoscopic Resection for Colitis-Associated Colorectal Neoplasia in Inflammatory Bowel Disease: Turning Visible into Resectable.
Maselli R, de Sire R, Massimi D, Franchellucci G, Busacca A, Castiglione F, Rispo A, Hassan C, Armuzzi A, Repici A. Maselli R, et al. Diagnostics (Basel). 2023 Dec 20;14(1):9. doi: 10.3390/diagnostics14010009. Diagnostics (Basel). 2023. PMID: 38201318 Free PMC article. Review.
References
- 1Ullman T, Croog V, Harpaz N et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;5085:1311–1319. - PubMed
- 2Bernstein C, Shanahan F, Weinstein W. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994, 71–75. - PubMed
- 3Blackstone MO, Riddell RH, Rogers BH et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366–374. - PubMed
- 4Befrits R, Ljung T, Jaramillo E et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002;45:615–620. - PubMed
- 5Jess T, Loftus EV, Velayos FS et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis 2006;12:669–676. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical